Presentation AHA 2022 Reduction of Lipoprotein(a) With Small Interfering RNA: Results of the OCEAN(a)-DOSE (TIMI 67) Trial Presenter: Michelle L. O’Donoghue November 07, 2022 REGISTER for free or LOG IN to view this content Lipids Coronary CAD Pharma Presentation AHA 2022 Up Next Presentation AHA 2022 Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial Presenter: Gregg W. Stone November 07, 2022 More slides + Presentation AHA 2022 ISCHEMIA-EXTEND: ISCHEMIA Extended Follow-Up Interim Report Presenter: Judith S. Hochman November 07, 2022 Presentation AHA 2022 Comparison of a Precision Care Strategy With Usual Testing To Guide Management Of Stable Patients With Suspected Coronary Artery Disease Presenter: Pamela S. Douglas November 07, 2022 We Recommend
Presentation AHA 2022 Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial Presenter: Gregg W. Stone November 07, 2022
Presentation AHA 2022 ISCHEMIA-EXTEND: ISCHEMIA Extended Follow-Up Interim Report Presenter: Judith S. Hochman November 07, 2022
Presentation AHA 2022 Comparison of a Precision Care Strategy With Usual Testing To Guide Management Of Stable Patients With Suspected Coronary Artery Disease Presenter: Pamela S. Douglas November 07, 2022